ARTICLE | Company News
Dynavax, National Institutes of Health infectious news
October 6, 2008 7:00 AM UTC
Dynavax received a five-year, $17 million contract from NIH's National Institute of Allergy and Infectious Diseases (NIAID) to develop vaccine adjuvant candidates for anthrax and other disease. Dynava...